Medical Market Report

Global Sexually Transmitted Disease (STD) Diagnosis Market By Type (Chlamydia testing, Syphilis testing, Gonorrhoea testing, and Others), By Application (Government organizations, Hospitals, Diagnostic clinics), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 135605
  • 16-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Global Sexually Transmitted Disease (STD) Diagnosis Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global sexually transmitted disease (std) diagnosis Market is segmented on the basis of Type, Application, and geography.
    The Global Sexually Transmitted Disease (STD) Diagnosis Market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.

    Sexually Transmitted Disease (STD) Diagnosis Market Scope:

    By type, the market is segmented into Chlamydia testing, Syphilis testing, Gonorrhoea testing, Herpes simplex virus testing, Human papilloma virus testing, and Human immunodeficiency virus testing. By Application, the market is divided into Government organizations, Hospitals, and Diagnostic clinics.
    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Abbott, Roche, Thermo Fisher Scientific, Aposcience, BCR Diagnostics, BD Medical, Biocartis, BioM rieux, Bio-Rad, Cepheid, Danaher, DiaSorin, Quidel, GenMark Diagnostics, Hologic, OraSure Technologies, and Qualigen.

    Key Market Segments

    Type

    Chlamydia testing
    Syphilis testing
    Gonorrhoea testing
    Herpes simplex virus testing
    Human papilloma virus testing
    Human immunodeficiency virus testing

    Application

    Government organizations
    Hospitals
    Diagnostic clinics

    Key Market Players included in the report:

    Abbott
    Roche
    Thermo Fisher Scientific
    Aposcience
    BCR Diagnostics
    BD Medical
    Biocartis
    BioM rieux
    Bio-Rad
    Cepheid
    Danaher
    DiaSorin
    Quidel
    GenMark Diagnostics
    Hologic
    OraSure Technologies
    Qualigen

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Global Sexually Transmitted Disease (STD) Diagnosis Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Global Sexually Transmitted Disease (STD) Diagnosis Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Global Sexually Transmitted Disease (STD) Diagnosis Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Sexually Transmitted Disease (STD) Diagnosis Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Global Sexually Transmitted Disease (STD) Diagnosis Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Global Sexually Transmitted Disease (STD) Diagnosis Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Global Sexually Transmitted Disease (STD) Diagnosis Market sub-markets, depending on key regions (various vital states).
    To analyze Global Sexually Transmitted Disease (STD) Diagnosis Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Global Sexually Transmitted Disease (STD) Diagnosis Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide Global Sexually Transmitted Disease (STD) Diagnosis Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Global Sexually Transmitted Disease (STD) Diagnosis Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

    2.1. Key Findings by Major Segments
    
2.2. Top strategies by Major Players3. Global Sexually Transmitted Disease (STD) Diagnosis Market Overview
    

    3.1. Global Sexually Transmitted Disease (STD) Diagnosis Market Dynamics
    

    3.1.1. Drivers
    
3.1.2. Opportunities
    
3.1.3. Restraints
    
3.1.4. Challenges3.2. PESTLE Analysis
    
3.3. Opportunity Map Analysis
    
3.4. PORTER’S Five Forces Analysis
    
3.5. Market Competition Scenario Analysis
    
3.6. Product Life Cycle Analysis
    
3.7. Opportunity Orbits
    
3.8. Manufacturer Intensity Map4. Global Sexually Transmitted Disease (STD) Diagnosis Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

    4.1. Global Sexually Transmitted Disease (STD) Diagnosis Market Analysis by Type: Introduction
    
4.2. Market Size and Forecast by Region
    
4.3. Chlamydia testing
    
4.4. Syphilis testing
    
4.5. Gonorrhoea testing
    
4.6. Herpes simplex virus testing
    
4.7. Human papilloma virus testing
    
4.8. Human immunodeficiency virus testing5. Global Sexually Transmitted Disease (STD) Diagnosis Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

    5.1. Global Sexually Transmitted Disease (STD) Diagnosis Market Analysis by Application: Introduction
    
5.2. Market Size and Forecast by Region
    
5.3. Government organizations
    
5.4. Hospitals
    
5.5. Diagnostic clinics6. Global Sexually Transmitted Disease (STD) Diagnosis Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

    6.1. North America
    

    6.1.1. North America Global Sexually Transmitted Disease (STD) Diagnosis Market: Regional Trend Analysis
    

    6.1.1.1. US
    
6.1.1.2. Canada
    
6.1.1.3. Mexico
    

    6.2.1. Europe
    

    6.2.1. Europe Global Sexually Transmitted Disease (STD) Diagnosis Market: Regional Trend Analysis
    

    6.2.1.1. Germany
    
6.2.1.2. France
    
6.2.1.3. UK
    
6.2.1.4. Russia
    
6.2.1.5. Italy
    
6.2.1.6. Rest of Europe
    

    6.3. Asia-Pacific
    

    6.3.1. Asia-Pacific Global Sexually Transmitted Disease (STD) Diagnosis Market: Regional Trend Analysis
    

    6.3.1.1. China
    
6.3.1.2. Japan
    
6.3.1.3. Korea
    
6.3.1.4. India
    
6.3.1.5. Rest of Asia
    

    6.4. Latin America
    

    6.4.1. Latin America Global Sexually Transmitted Disease (STD) Diagnosis Market: Regional Trend Analysis
    

    6.4.1.1. Brazil
    
6.4.1.2. Argentina
    
6.4.1.3. Rest of Latin America
    

    6.5. Middle East and Africa
    

    6.5.1. Middle East and Africa Global Sexually Transmitted Disease (STD) Diagnosis Market: Regional Trend Analysis
    

    6.5.1.1. GCC
    
6.5.1.2. South Africa
    
6.5.1.3. Israel
    
6.5.1.4. Rest of MEA
    
7. Global Sexually Transmitted Disease (STD) Diagnosis Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

    7.1. Market Share Analysis
    
7.2. Company Profiles
    
7.3. Abbott
    

    7.3.1. Company Overview
    
7.3.2. Financial Highlights
    
7.3. 3. Product Portfolio
    
7.3.4. SWOT Analysis
    
7.3.5. Key Strategies and Developments7.4. Roche
    

    7.4.1. Company Overview
    
7.4.2. Financial Highlights
    
7.4.3. Product Portfolio
    
7.4. 4. SWOT Analysis
    
7.4.5. Key Strategies and Developments7.5. Thermo Fisher Scientific
    

    7.5.1. Company Overview
    
7.5.2. Financial Highlights
    
7.5.3. Product Portfolio
    
7.5.4. SWOT Analysis
    
7.5. 5. Key Strategies and Developments7.6. Aposcience
    

    7.6.1. Company Overview
    
7.6.2. Financial Highlights
    
7.6.3. Product Portfolio
    
7.6.4. SWOT Analysis
    
7.6.5. Key Strategies and Developments7.7. BCR Diagnostics
    

    7.7.1. Company Overview
    
7.7.2. Financial Highlights
    
7.7.3. Product Portfolio
    
7.7.4. SWOT Analysis
    
7.7.5. Key Strategies and Developments7.8. BD Medical
    

    7.8.1. Company Overview
    
7.8.2. Financial Highlights
    
7.8.3. Product Portfolio
    
7.8.4. SWOT Analysis
    
7.8.5. Key Strategies and Developments7.9. Biocartis
    

    7.9.1. Company Overview
    
7.9.2. Financial Highlights
    
7.9.3. Product Portfolio
    
7.9.4. SWOT Analysis
    
7.9.5. Key Strategies and Developments7. 10.BioM rieux
    

    7. 10.1. Company Overview
    
7. 10.2. Financial Highlights
    
7. 10.3. Product Portfolio
    
7. 10.4. SWOT Analysis
    
7. 10.5. Key Strategies and Developments7. 11. Bio-Rad
    

    7. 11.1. Company Overview
    
7. 11.2. Financial Highlights
    
7. 11.3. Product Portfolio
    
7. 11.4. SWOT Analysis
    
7. 11.5. Key Strategies and Developments7. 12. Cepheid
    

    7. 12.1. Company Overview
    
7. 12.2. Financial Highlights
    
7. 12.3. Product Portfolio
    
7. 12.4. SWOT Analysis
    
7. 12.5. Key Strategies and Developments7. 13. Danaher
    

    7. 13.1. Company Overview
    
7. 13.2. Financial Highlights
    
7. 13.3. Product Portfolio
    
7. 13.4. SWOT Analysis
    
7. 13.5. Key Strategies and Developments7. 14. DiaSorin
    

    7. 14.1. Company Overview
    
7. 14.2. Financial Highlights
    
7. 14.3. Product Portfolio
    
7. 14.4. SWOT Analysis
    
7. 14.5. Key Strategies and Developments7. 15. Quidel
    

    7. 15.1. Company Overview
    
7. 15.2. Financial Highlights
    
7. 15.3. Product Portfolio
    
7. 15.4. SWOT Analysis
    
7. 15.5. Key Strategies and Developments7. 16. GenMark Diagnostics
    

    7. 16.1. Company Overview
    
7. 16.2. Financial Highlights
    
7. 16.3. Product Portfolio
    
7. 16.4. SWOT Analysis
    
7. 16.5. Key Strategies and Developments7. 17. Hologic
    

    7. 17.1. Company Overview
    
7. 17.2. Financial Highlights
    
7. 17.3. Product Portfolio
    
7. 17.4. SWOT Analysis
    
7. 17.5. Key Strategies and Developments7. 18. OraSure Technologies
    

    7. 18.1. Company Overview
    
7. 18.2. Financial Highlights
    
7. 18.3. Product Portfolio
    
7. 18.4. SWOT Analysis
    
7. 18.5. Key Strategies and Developments7. 19. Qualigen
    

    7. 19.1. Company Overview
    
7. 19.2. Financial Highlights
    
7. 19.3. Product Portfolio
    
7. 19.4. SWOT Analysis
    
7. 19.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10.Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.